Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Federico Lombardi Added: 3 years ago
Atrial fibrillation (AF) is the most common clinical arrhythmia with a relevant socio-economic impact.1–3 Patients with atrial fibrillation are characterised by symptoms such as palpitations and shortness of breath; they have reduced exercise capacity and are subject to a higher risk of thromboembolic events. In spite of a relatively simple diagnosis, management of AF patients is difficult for… View more
Research Area(s) / Expertise:

Electrophysiology & Arrhythmia

Atrial Arrhythmias

Atrial Fibrillation

Pacing, Defibrillators & Cardiac Resynchronisation Therapy

Ventricular Arrhythmias

Job title: University Hospital Coventry, UK
Prof Osman is Consultant Cardiologist / Electrophysiologist, University Hospital Coventry, UK, Honorary Professor of Cardiology (Warwick Medical School)Lead for Cardiac Rhythm Management Several research interests in the field of arrhythmia, including CRT response, AF and Ablation.Special interest: Cardiac Electrophysiology: Atrial Fibrillation, SVT, Atrial Flutter, Ventricular Arrhythmias… View more
Author(s): Eyal Nof , William G Stevenson , Roy John Added: 3 years ago
Sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) are typically a manifestation of significant structural heart disease and often associated with a high risk of sudden cardiac death. Implantable cardioverter defibrillators (ICDs) remain the mainstay of therapy for prevention of sudden cardiac death associated with these arrhythmias.1 However, ICDs treat the arrhythmia after… View more
Job title: Director
Dr Johannes Brachmann is a Director, REGIOMED Centrum for Cardiology and Angiology and Leader of the Medical Boards REGIOMED-KLINIKEN and Chief physician II at Clinic cardiology, angiology, pneumology. Dr Brachmann received a Research fellowship of the German Research Foundation at the University of Oklahoma, USA From 1981 to 1988 he worked as Head of the clinical and experimental… View more
Job title: Senior Consultant in Electrophysiology and Devices
Professor Jan Steffel is a Cardiologist and Senior Consultant in Electrophysiology and Devices at the Hirslanden Clinic in Zurich and Professor of Cardiology at the University of Zurich. He has over 150 publications in international and national journals and is board-certified in Internal Medicine and Cardiology.He was Associate Editor for the European Heart Journal from 2012 and became Deputy… View more
Author(s): KR Julian Chun , Boris Schmidt , Devi Nair , et al Added: 1 year ago
Rhythm Interventions Online 2022 – one of the leading practical education broadcasts in electrophysiology – took place 30 November – 2 December 2022. Bringing together a faculty of over 40 key opinion leaders, seven case centres from both sides of the Atlantic and a global audience of over 2,500 delegates, RIO 2022 delivered best-in-class education curated to support practical learning and… View more
Author(s): Theodoros A Zografos Added: 3 years ago
Dear Sir, I read with great interest the elegant review by Mukherjee and colleagues on prophylactic VT ablation in the latest issue of the journal (AER 6(3)125-8).1 The concept is indeed revolutionary, and should extend the boundaries of interventional electrophysiology. However, such an approach cannot be feasible without rationalising patient selection. Current guidelines’ recommendations,… View more
Research Area(s) / Expertise:

Heart Failure

Devices

Cardiomyopathy

Digital Health

Personal History Dr. Jouhra is based in London, where he works in the Department of Cardiology of St George’s University Hospital NHS Foundation Trust. Academic History Dr. Jouhra began his cardiology training at King’s College Hospital in Oct 2011 as a Locum Appointment Trainee for 1 year. During that year, he developed a specialist interest in heart failure and went on to secure a… View more
Author(s): Michael R Gold Added: 3 years ago
Dr Michael R Gold (Medical University of South Carolina, Charleston, SC, US) discusses the primary results of the UNTOUCHED trial. The UNTOUCHED trial assesed the 18-month incidence of inappropriate shocks in subjects implanted with the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) for primary prevention of sudden cardiac death. Questions: 1. What was the rationale behind the UNTOUCHED… View more
Author(s): Alfred Buxton Added: 3 years ago
“What Would He Do Next?” I met Mark Josephson in 1973 when he came to the Hospital of the University of Pennsylvania (HUP) as a cardiology fellow. He had just completed 2 years at the US Public Health Service Hospital on Staten Island where he began his career in clinical electrophysiology. I was beginning medical internship at the same time. Even though Mark was among the most junior members of… View more